ALS acquires stake in European pharmaceutical business Nuvisan
29/07/2021
ALS expands Life Sciences service offering and geographic footprint with acquisition of 49% stake in European Pharmaceutical business.
See the full document here.
Últimas notícias
ALS Portugal © 2013
